Pulmonary delivery of curcumin and quercetin nanoparticles for lung cancer – Part 2: Toxicity and endocytosis
Authors:
- Ching-Yee LooCLChing-Yee Loo
- Daniela TrainiDTDaniela Traini
- Paul M. YoungPaul M. Young
- Thaigarajan ParumasivamTPThaigarajan Parumasivam
- Wing-Hin LeeWLWing-Hin Lee
- 16 March 2023
- journal article
- research article
- Published by Elsevier in Journal of Drug Delivery Science and Technology
- Vol. 82
Abstract
No abstract availableKeywords
Funding Information
- University of Kuala Lumpur
- Universiti Kuala Lumpur
- National Health and Medical Research Council (APP APP1173363)
This publication has 63 references indexed in Scilit:
- The Chemistry of Curcumin: From Extraction to Therapeutic AgentMolecules, 2014
- Recent advances in curcumin nanoformulation for cancer therapyExpert Opinion on Drug Delivery, 2014
- Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cellsInternational Journal of Pharmaceutics, 2013
- Assessing dose-dependent differences in DNA-damage, p53 response and genotoxicity for quercetin and curcuminToxicology in Vitro, 2013
- Regulation of Wnt signaling activity for growth suppression induced by quercetin in 4T1 murine mammary cancer cellsInternational Journal of Oncology, 2013
- Phase IIa Clinical Trial of Curcumin for the Prevention of Colorectal NeoplasiaCancer Prevention Research, 2011
- Solubility and solution thermodynamic properties of quercetin and quercetin dihydrate in subcritical waterJournal of Food Engineering, 2010
- Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and managementNutrition Reviews, 2010
- Interfering with ROS Metabolism in Cancer Cells: The Potential Role of QuercetinCancers, 2010
- Oxidative stress and redox regulation of lung inflammation in COPDEuropean Respiratory Journal, 2006